Senior Director, Global Medical Affairs Strategy - Solid Tumors

At Genmab, we're committed to building extra[not]ordinary futures together, by developing antibody products and pioneering, knock-your-socks-off therapies that change the lives of patients and the future of cancer treatment and serious diseases. From our people who are caring, candid, and impact-driven to our business, which is innovative and rooted in science, we believe that being proudly unique, determined to be our best, and authentic is essential to fulfilling our purpose.
The Role
Reporting to the Head of Global Medical Affairs Strategy (ST), the Global Medical Affairs Sr. Director will be the subject matter expert responsible for leading the development and execution of the Global Medical Affairs strategic and tactical plans including launch readiness and life cycle management for select solid tumor pipeline program.
We have a hybrid model that requires being onsite in Princeton, NJ 60% of the time.
Responsibilities
The Global Medical Affairs Sr. Director should have strong commercial aptitude and experience, including proven ability to translate and align commercial and scientific goals and objectives into actions. He/she will work as an integral part of the Compound Development Team (CDT) and will in close alignment with Head of Global Medical Affairs Strategy (ST) and in close collaboration with the cross-functional and alliance partners, provide input and strategic direction for the program peri- and post-launch. He/she will also support data generation and life cycle management initiatives as well as establish and maintain relationships with global thought leaders and clinical collaborators.
Specific responsibilities for this role will include but are not limited to:

• Develop and execute the overall Medical Affairs Strategy for designated product in NSCLC therapeutic area
• Serve on Compound Development Team as Global Medical Affairs representative; Co-Lead Global Commercialization Team
• Serve as the Medical Affairs lead on lifecycle strategy, including evidence generation strategy development and execution of Phase 3b/4 Medical Affairs led interventional and observational clinical trials
• Accountable/Responsible for Global/Regional MA Plans in collaboration and alignment with the CDT, regions, alliance collaborators and GMA functional teams
• Accountable/Responsible for creating and executing on the GMA launch readiness and launch plans
• Accountable/Responsible for IEGP; Lead global efforts oversee development & updates of AOIs including partnering with CORE for HEOR EGP Assure appropriate close coordination with commercial and marketing teams to support their efforts, including medical expert support of product pre-launch/launch
• Effectively manage and interact with key thought leaders, patient advocacy groups and institutions to engage in scientific and medical exchange to meet the needs of patients, advance the field of study and Genmab programs
• Play an integral role in the planning and execution of Global advisory boards and other Key thought leader meetings related to an asset/or therapeutic area
• Collaborate with the field/regional teams and support reactive material development to address healthcare provider questions
• Drive creation and exceution of training plans in collaboration with Training Lead; Proactively identify training gaps
• Collaborate with medical information specialists on the development of medical information letters and documents
• Coordinate with clinical operations, medical and translational medicine teams on strategic priorities and study support
• Collaborate with medical communications on the preparation of manuscripts, abstracts and presentations for scientific meetings as well as other scientific communications initiatives
• Oversee the development of (and updates to) the yearly global publications plan for assigned product(s) and ensure optimal execution of plan
• Provide guidance in the development of strategies to demonstrate the value of disease/products with a focus on outcomes meaningful to payer and clinical decision-makers
• Provide scientific/medical input into local regulatory/reimbursement/policy related documents and interactions
• Participate in medical review of branded and unbranded promotional materials, market access and health economics and outcomes research (HEOR) materials and medical communications materials to ensure accuracy, currency, scientific balance and compliance with internal policies and procedures
• Serve as a medical and content expert for internal and external stakeholders, including contribution of therapeutic area expertise for clinical development plans and presentations for internal training as well as external audiences
• Represent Genmab at key Global medical conferences/meetings
• Contribute to the development of internal guidance and resource documents
• Contribute as requested to the development/editing of departmental SOPs addressing processes and procedures necessary to achieve organizational objectives and for complying with government regulations and company policy. Ensures adherence to policies/procedures

Requirements

• Scientific or Medical Degree (Pharm D, PhD, MD) required
• 10+ years of Medical Affairs and/or clinical development background in oncology
• Global Medical Affairs and Global launch experience is a must, with strong understanding of NSCLC therapeutic and commercial landscapes
• People Management experience is a must
• Ability to work successfully under pressure in a fast-paced environment and with tight timelines
• Demonstrated ability to lead strategically, drive performance, build alignment, inform, negotiate, and collaborate across partnerships
• Ability to lead collaboratively across various internal stakeholders and develop trusted partnerships
• A strong ability to interpret and articulate clinical/HEOR data and the impact on development programs
• In depth understanding of compliance and regulatory requirements for pharmaceutical Medical Affairs, R&D and Commercial work
• Knowledge of evidence-based medicine concepts, applied biostatistics and health economics are desirable
• Demonstrated organizational skills to manage multiple projects simultaneously, prioritize projects effectively and communicate at all levels within the company
• Strong written and verbal communication skills (including presentation skills)
• Ability to travel internationally to conferences and meetings, which will include occasional weekend travel

For US based candidates, the proposed salary band for this position is as follows:
$255,000.00---$425,000.00
The actual salary offer will carefully consider a wide range of factors, including your skills, qualifications, experience, and location. Also, certain positions are eligible for additional forms of compensation, such as bonuses.
About You

• You are passionate about our purpose and genuinely care about our mission to transform the lives of patients through innovative cancer treatment
• You bring rigor and excellence to all that you do. You are a fierce believer in our rooted-in-science approach to problem-solving
• You are a generous collaborator who can work in teams with diverse backgrounds
• You are determined to do and be your best and take pride in enabling the best work of others on the team
• You are not afraid to grapple with the unknown and be innovative
• You have experience working in a fast-growing, dynamic company (or a strong desire to)
• You work hard and are not afraid to have a little fun while you do so

Locations
Genmab leverages the effectiveness of an agile working environment, when possible, for the betterment of employee work-life balance. Our offices are designed as open, community-based spaces that work to connect employees while being immersed in our state-of-the-art laboratories. Whether you're in one of our collaboratively designed office spaces or working remotely, we thrive on connecting with each other to innovate.
About Genmab
Genmab is an international biotechnology company with a core purpose guiding its unstoppable team to strive towards improving the lives of patients through innovative and differentiated antibody therapeutics. For more than 20 years, its passionate, innovative and collaborative team has invented next-generation antibody technology platforms and leveraged translational research and data sciences, which has resulted in a proprietary pipeline including bispecific T-cell engagers, next-generation immune checkpoint modulators, effector function enhanced antibodies and antibody-drug conjugates. To help develop and deliver novel antibody therapies to patients, Genmab has formed 20+ strategic partnerships with biotechnology and pharmaceutical companies. By 2030, Genmab's vision is to transform the lives of people with cancer and other serious diseases with Knock-Your-Socks-Off (KYSO™) antibody medicines.
Established in 1999, Genmab is headquartered in Copenhagen, Denmark with locations in Utrecht, the Netherlands, Princeton, New Jersey, U.S. and Tokyo, Japan.
Our commitment to diversity, equity, and inclusion
We are committed to fostering workplace diversity at all levels of the company and we believe it is essential for our continued success. No applicant shall be discriminated against or treated unfairly because of their race, color, religion, sex (including pregnancy, gender identity, and sexual orientation), national origin, age, disability, or genetic information. Learn more about our commitments on our website.
Genmab is committed to protecting your personal data and privacy. Please see our privacy policy for handling your data in connection with your application on our website https://www.genmab.com/privacy.
Please note that if you are applying for a position in the Netherlands, Genmab's policy for all permanently budgeted hires in NL is initially to offer a fixed-term employment contract for a year, if the employee performs well and if the business conditions do not change, renewal for an indefinite term may be considered after the fixed-term employment contract.